Thread Appoints Chief Strategy Officer, Senior Vice President eCOA
Keli Platco joins Thread to support eCOA and technology solutions dedicated to accelerating research for everyone, everywhere
CARY, N.C., November 8, 2023 – Thread, a leading decentralized research and electronic clinical outcome assessment (eCOA) provider, today announced the appointment of Keli Platco as chief strategy officer and senior vice president of eCOA. Ms. Platco brings to Thread more than 20 years of clinical trial industry experience. She will work with the executive management team to drive Thread’s strategy and investments in its suite of technology solutions that support pharmaceutical and biotech organizations in advancing research.
Ms. Platco has a strong track record of leading teams in developing and implementing strategies that address researchers’ needs and achieve business objectives. During an 18-year career with Signant Health (previously Bracket Global and CRF Health), Ms. Platco was promoted to leadership roles encompassing client services and project management. She also led operations for ClinOne. Most recently, Ms. Platco served as general manager of Clinical Endpoint Solutions for global provider WCG.
Thread Co-Founder and CEO John Reites said:
“Keli brings a unique blend of industry expertise, customer focus, and eCOA experience to Thread. She is an important addition to our executive management team as we continue to look at new ways to enrich our eCOA offering and solutions that enable patient-centered research studies.”
Ms. Platco, who assumes her new position effective immediately, added:
“I am truly honored by the opportunity to join the Thread team at this pivotal time in our industry. I joined this industry 20 years ago because I was compelled by the mission to improve patient lives in a positive way. This mission embodies Thread, which is relentlessly focused on supporting clients in bringing life-changing therapies to everyone, everywhere.”
To learn more about Keli and Thread’s executive management team, click here.
Thread’s® purpose is to leverage its decentralized research platform to enable studies for everyone, everywhere. The company’s uniquely combined clinical research technology and consulting services help life science organizations to design, operate, and scale next-generation research studies and electronic clinical outcome assessments (eCOA) programs for participants, sites, and study teams. Through its comprehensive platform and scientific expertise, Thread empowers studies to be accessible, efficient, and centered on the patient. Backed by health care investors Water Street Healthcare Partners and JLL Partners, Thread is recognized as a leader by Everest Group’s Decentralized Clinical Trial Product PEAK Matrix® Assessment 2021/2022 and positioned in the Leader's Category of the 2022 IDC MarketScape for R&D Decentralized Clinical Trial Technology Solutions Vendor Assessment 2022. Visit Threadresearch.com to learn more.